Turkish COVID-19 drug ready to be registered, minister announces
Turkish scientists have produced a domestic reproduction of Favipiravir, widely used to treat COVID-19. Industry and Technology Minister Mustafa Varank said that once the drug was registered and mass produced, it would also be exported.
Duvar English
Turkey's Scientific and Technological Research Council (TÜBİTAK) synthesized a domestic reproduction of Favipiravir, widely used to treat COVID-19, and are waiting for the new formula to be registered.
A group of 32 scientists from Istanbul Medipol University used only domestic ingredients, Industry and Technology Minister Mustafa Varank said on June 12 while a sample of the drug was presented to the public.
"Our Health Minister said that he had given the orders on the quick licensing of the medicine," Varank added.
While Atabay Medicine lended its facilities to the marketing of the drug, Minister Varank said that the drug would be exported once the licensing was complete.